Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06950788 · ClinicalTrials.gov registry record
Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
A clinical trial of Cirrhosis, Liver and Transplant; Failure, Liver, sponsored by University of Chicago.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06950788 is a study of Cirrhosis, Liver and Transplant; Failure, Liver that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 60 participants, below the 240-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06950788, a study of Cirrhosis, Liver and Transplant; Failure, Liver, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to establish risk factors for post-transplant in adult individuals with cirrhosis without diabetes undergoing liver transplant evaluation. The question being addressed is: can laboratory work, anthropometric tests, functional tests, imaging, and advanced measurements such as wrist actigraphy, continuous glucose monitoring, or oral glucose tolerance testing predict the development of diabetes after liver transplant? Participants will be asked to periodically participate in wearing a continuous glucose monitor and wrist actigraph and obtain an oral glucose tolerance test both before and after liver transplant.
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-03-12 |
| Est. Completion | 2031-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06950788
The ClinicalTrials.gov registry entry for NCT06950788 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 240-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (75% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cirrhosis, Liver appearing as the primary indexed condition, and to 0 interventions.
NCT06950788 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06950788 about?
NCT06950788 is a clinical study titled "Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant". The goal of this observational study is to establish risk factors for post-transplant in adult individuals with cirrhosis without diabetes undergoing liver transplant evaluation. The question being addressed is: can laboratory work, anthropometric tests, functional tests, imaging, and advanced meas...
What is the current status of trial NCT06950788?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2024-03-12. Estimated completion is 2031-01.
What conditions does trial NCT06950788 study?
This clinical trial studies the following conditions: Cirrhosis, Liver, Transplant; Failure, Liver, Diabetes Mellitus Risk, Transplant-Related Disorder.
Who is sponsoring clinical trial NCT06950788?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06950788 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis, Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
RECRUITING · Phase 1
-
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
RECRUITING · Phase 4
-
Measuring Patient Reported Needs in Outpatient Liver Disease Management
RECRUITING
-
Molecular Mechanism of Exercise in Cirrhosis
RECRUITING · NA
-
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
RECRUITING · Phase 2
-
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.